191 related articles for article (PubMed ID: 38027017)
1. HLA-targeted sequencing reveals the pathogenic role of HLA-B*15:02/HLA-B*13:01 in albendazole-induced liver failure: a case report and a review of the literature.
Liao JM; Zhan Y; Zhang Z; Cui JJ; Yin JY
Front Pharmacol; 2023; 14():1288068. PubMed ID: 38027017
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
Kaniwa N; Saito Y
J Hum Genet; 2013 Jun; 58(6):317-26. PubMed ID: 23635947
[TBL] [Abstract][Full Text] [Related]
3. Genetics of immune-mediated adverse drug reactions: a comprehensive and clinical review.
Yip VL; Alfirevic A; Pirmohamed M
Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):165-75. PubMed ID: 24777842
[TBL] [Abstract][Full Text] [Related]
4. Acute hepatitis in a paediatric patient: immune-mediated drug-induced liver injury or albendazole-induced autoimmune hepatitis?
Dragutinović N; Barać A; Stevanović G; Đorđić I; Paglietti B; Micić J; Aleksić E; Stojnić J; Martinov Nestorov J
J Infect Dev Ctries; 2022 Oct; 16(10):1660-1663. PubMed ID: 36332223
[TBL] [Abstract][Full Text] [Related]
5. Single-nucleotide polymorphisms of
Yang WN; Pang LL; Zhou JY; Qiu YW; Miao L; Wang SY; Liu XZ; Tan KA; Shi WW; Wang GQ; Hou FQ
World J Gastroenterol; 2020 Mar; 26(12):1329-1339. PubMed ID: 32256020
[TBL] [Abstract][Full Text] [Related]
6. HLA Association with Drug-Induced Adverse Reactions.
Fan WL; Shiao MS; Hui RC; Su SC; Wang CW; Chang YC; Chung WH
J Immunol Res; 2017; 2017():3186328. PubMed ID: 29333460
[TBL] [Abstract][Full Text] [Related]
7.
Petros Z; Kishikawa J; Makonnen E; Yimer G; Habtewold A; Aklillu E
Front Pharmacol; 2017; 8():90. PubMed ID: 28289388
[TBL] [Abstract][Full Text] [Related]
8. Newly identified genetic variants associated with idiosyncratic drug-induced liver injury.
Stolz A
Curr Opin Gastroenterol; 2022 May; 38(3):230-238. PubMed ID: 35645018
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles.
Lucena MI; Molokhia M; Shen Y; Urban TJ; Aithal GP; Andrade RJ; Day CP; Ruiz-Cabello F; Donaldson PT; Stephens C; Pirmohamed M; Romero-Gomez M; Navarro JM; Fontana RJ; Miller M; Groome M; Bondon-Guitton E; Conforti A; Stricker BH; Carvajal A; Ibanez L; Yue QY; Eichelbaum M; Floratos A; Pe'er I; Daly MJ; Goldstein DB; Dillon JF; Nelson MR; Watkins PB; Daly AK; ; ; ; ;
Gastroenterology; 2011 Jul; 141(1):338-47. PubMed ID: 21570397
[TBL] [Abstract][Full Text] [Related]
10. Idiosyncratic drug-induced liver injury: an update on the 2007 overview.
Hussaini SH; Farrington EA
Expert Opin Drug Saf; 2014 Jan; 13(1):67-81. PubMed ID: 24073714
[TBL] [Abstract][Full Text] [Related]
11. Significant association between HLA-B*35:01 and onset of drug-induced liver injury caused by Kampo medicines in Japanese patients.
Nakamura R; Arakawa N; Tanaka Y; Uchiyama N; Sekine A; Mashimo Y; Tsuji K; Kagawa T; Sato K; Watanabe M; Aiso M; Hiasa Y; Takei Y; Ohira H; Ayada M; Tsukagoshi E; Maekawa K; Tohkin M; Saito Y; Takikawa H
Hepatol Res; 2023 May; 53(5):440-449. PubMed ID: 36583370
[TBL] [Abstract][Full Text] [Related]
12. Association of human leukocyte antigen-B*13:01 with dapsone-induced liver injury.
Devarbhavi H; Patil M; Menon M
Br J Clin Pharmacol; 2022 Mar; 88(3):1369-1372. PubMed ID: 34427944
[TBL] [Abstract][Full Text] [Related]
13. Critical Review of Gaps in the Diagnosis and Management of Drug-Induced Liver Injury Associated with Severe Cutaneous Adverse Reactions.
Villanueva-Paz M; Niu H; Segovia-Zafra A; Medina-Caliz I; Sanabria-Cabrera J; Lucena MI; Andrade RJ; Alvarez-Alvarez I
J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830594
[TBL] [Abstract][Full Text] [Related]
14. Idiosyncratic Drug-Induced Liver Injury Due to Ciprofloxacin: A Report of Two Cases and Review of the Literature.
Radovanovic M; Dushenkovska T; Cvorovic I; Radovanovic N; Ramasamy V; Milosavljevic K; Surla J; Jecmenica M; Radulovic M; Milovanovic T; Dumic I
Am J Case Rep; 2018 Sep; 19():1152-1161. PubMed ID: 30266895
[TBL] [Abstract][Full Text] [Related]
15. Drug-induced liver injury associated with severe cutaneous adverse drug reactions: A nationwide study in Taiwan.
Huang YS; Wu CY; Chang TT; Peng CY; Lo GH; Hsu CW; Hu CT; Huang YH
Liver Int; 2021 Nov; 41(11):2671-2680. PubMed ID: 34153177
[TBL] [Abstract][Full Text] [Related]
16. Genetic and immune predictors for hypersensitivity syndrome to antiepileptic drugs.
Neuman MG; Cohen L; Nanau RM; Hwang PA
Transl Res; 2012 May; 159(5):397-406. PubMed ID: 22500513
[TBL] [Abstract][Full Text] [Related]
17. The HLA-B*15:02 polymorphism and Tegretol
Chouchi M; Kaabachi W; Tizaoui K; Daghfous R; Aidli SE; Hila L
Rev Neurol (Paris); 2018 May; 174(5):278-291. PubMed ID: 29685430
[TBL] [Abstract][Full Text] [Related]
18. Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions.
Karnes JH; Miller MA; White KD; Konvinse KC; Pavlos RK; Redwood AJ; Peter JG; Lehloenya R; Mallal SA; Phillips EJ
Annu Rev Pharmacol Toxicol; 2019 Jan; 59():463-486. PubMed ID: 30134124
[TBL] [Abstract][Full Text] [Related]
19. Genetic Factors Influencing Drug-Induced Liver Injury: Do They Have a Role in Prevention and Diagnosis?
Clare KE; Miller MH; Dillon JF
Curr Hepatol Rep; 2017; 16(3):258-264. PubMed ID: 28856081
[TBL] [Abstract][Full Text] [Related]
20. Albendazole-induced liver injury: a case report.
Ríos D; Restrepo JC
Colomb Med (Cali); 2013 Apr; 44(2):118-20. PubMed ID: 24892458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
